Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Conditions: Malignant Mesothelioma
Start Date: January 1, 1900
Phase:
Status: Active, not recruiting
NCT ID: NCT00898547
Study Type: Observational
Intervention: Other: immunoenzyme technique/Other: laboratory biomarker analysis
Study Design:
Results: No Results Available
Sponsors: Cancer and Leukemia Group B/National Cancer Institute (NCI)
Ages: Adult/Senior
Enrollment: 47
Funded By: NETWORK/NIH
First Received: May 9, 2009
End Date: January 1, 1900
Last Updated: May 16, 2009
Last Verified: November 1, 2006

Search for asbestos exposure sites and asbestos companies in all 50 states.